Alpha 2.0
Login Register
» Authors » Velella Righini

Velella Righini

Explore the profile of Velella Righini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 47
Followers 0
Related Specialties
Endocrinology
Pharmacology
General Medicine
Top 10 Co-Authors
Maurizio Bevilacqua
Massimo Barrella
Ligia J Dominguez
Tarcisio Vago
Mario Barbagallo
Valeria Valdes
Enrica Chebat
Stefano Carda
Jean-Pierre Famaey
Jean-Pierre Devogelaer
Published In
Eur J Endocrinol
J Clin Endocrinol Metab
J Bone Miner Res
Surgery
Curr Ther Res Clin Exp
Affiliations
Soon will be listed here.
Recent Articles
1.
Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point...
Bevilacqua M, Guazzini B, Righini V, Barrella M, Toscano R, Chebat E
Curr Ther Res Clin Exp . 2014 Mar; 65(4):330-44. PMID: 24672088
Background: Diabetic dyslipidemia is characterized by greater triglyceridation of all lipoproteins and low levels of plasma high-density lipoprotein cholesterol (HDL-C). In this condition, the serum level of low-density lipoprotein cholesterol...
2.
Effect of a mixture of calcium, vitamin D, inulin and soy isoflavones on bone metabolism in post-menopausal women: a retrospective analysis
Bevilacqua M, Righini V, Certan D, Gandolini G, Alemanni M
Aging Clin Exp Res . 2013 Aug; 25(6):611-7. PMID: 23907774
Objectives: Aging might affect the effectiveness of the sole supplementation of calcium and vitamin D in post-menopausal women, due to the development of vitamin D resistance in the gut, which...
3.
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects
Invernizzi M, Carda S, Righini V, Baricich A, Cisari C, Bevilacqua M
Eur J Endocrinol . 2012 Aug; 167(4):491-7. PMID: 22872468
Background: Normocalcemic primary hyperparathyroidism (PHPT-N) is a condition that may have similar long-term implications to primary hyperparathyroidism (PHPT); however, differential diagnosis and treatment for parathyroid disorders are not clearly defined....
4.
Different vitamin D substrate-product relationship after oral vitamin D supplementation in familial benign hypercalcemia, primary hyperparathyroidism, and healthy controls
Bevilacqua M, Invernizzi M, Righini V, Carda S, Cisari C
Eur J Endocrinol . 2011 Feb; 164(5):833-8. PMID: 21310873
Context: In healthy subjects and in patients with primary hyperparathyroidism (PH), the administration of a low dose of 25(OH)D (25 μg/day) increases the serum levels of both 25(OH)D and 1,25(OH)(2)D....
5.
Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: role of phosphate in the rapid control of parathyroid hormone release
Bevilacqua M, Dominguez L, Righini V, Vago T, Foschi D, Corsi F, et al.
Surgery . 2010 Apr; 147(5):655-61. PMID: 20403518
Background: It is generally considered that changes in serum phosphate levels do not alter parathyroid hormone (PTH) secretion in the absence of concomitant changes in ionized serum calcium level in...
6.
Vitamin D substrate-product relationship in idiopathic hypercalciuria
Bevilacqua M, Dominguez L, Gandolini G, Valdes V, Vago T, Righini V, et al.
J Steroid Biochem Mol Biol . 2008 Nov; 113(1-2):3-8. PMID: 19013526
Absorptive hypercalciuria (AH) is associated with elevated levels of 1,25-dihydroxyvitamin D (1,25(OH)(2)D). While no increase of 1,25(OH)(2)D after oral administration of 25-hydroxyvitamin D (25OHD) at high doses has been claimed...
7.
Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes
Bevilacqua M, Righini V, Barrella M, Vago T, Chebat E, Dominguez L
Adv Ther . 2006 Mar; 22(6):527-42. PMID: 16510370
The lipid triad is the association of small, dense (sd) low-density lipoprotein (LDL), low high-density lipoprotein (HDL), and hypertriglyceridemia, all of which play a role in coronary artery disease in...
8.
Dissimilar PTH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hyperparathyroidism, and normal subjects: a useful tool for differential diagnosis
Bevilacqua M, Dominguez L, Righini V, Valdes V, Vago T, Leopaldi E, et al.
J Bone Miner Res . 2006 Feb; 21(3):406-12. PMID: 16491288
Unlabelled: We analyzed gastrin, PTH, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, mild primary hyperparathyroidism, and normal controls. We observed diverse hormonal responses that may help...
9.
Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis
Manicourt D, Bevilacqua M, Righini V, Famaey J, Devogelaer J
Drugs R D . 2005 Sep; 6(5):261-71. PMID: 16128596
Background And Aim: Because in vitro studies have shown that nimesulide not only preferentially inhibits COX-2 but also reduces the action/release of pro-inflammatory cytokines, down-regulates the synthesis and/or activity of...
10.
Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study
Bevilacqua M, Devogelaer J, Righini V, Famaey J, Manicourt D
Int J Clin Pract Suppl . 2005 Jul; (144):13-9. PMID: 16035398
This prospective preliminary single-blind study was conducted in patients suffering from osteoarthritis (OA) and requiring non-steroidal anti-inflammatory drugs (NSAIDs) to determine to what extent nimesulide (200 mg/day) and ibuprofen (1200...